Clinical Trials Browser

Phase 2/3 × Interventional × Rivaroxaban × Clear all

NCT05920343 2025-07-10

PREVENT-GU

Phase 2/3 Recruiting

Classical hematologyGenitourinary

Urogenital Neoplasms, Urologic Neoplasms, Venous Thromboembolism

NCT03428373 2024-02-29

RithMM

Phase 2/3 Unknown

Multiple Myeloma